Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clinic. 2021;71(3):209–49.
Global Burden of Disease Cancer Collaboration. Global, Regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990–2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–68. https://doi.org/10.1001/jamaoncol.2019.2996.
Article PubMed Central Google Scholar
Kudela E, et al. 2022 HPV-associated breast cancer: myth or fact? Pathogens. 2022;11(12):12. https://doi.org/10.3390/pathogens11121510.
Miller KD, et al. 2016 Cancer treatment and survivorship statistics. CA: A Cancer J Clinic. 2016;66(4):271–89. https://doi.org/10.3322/caac.21349.
Carlberg C, Muñoz A. An update on vitamin D signaling and cancer. Seminars Cancer Biol. 2022;79:217–30. https://doi.org/10.1016/j.semcancer.2020.05.018.
Baltzell KA, Shen HM, Krishnamurthy S, Sison JD, Nuovo GJ, Buehring GC. Bovine leukemia virus linked to breast cancer but not coinfection with human papillomavirus: case control study of women in Texas. Cancer. 2018;124(7):1342–9. https://doi.org/10.1002/cncr.31169.
Burk RD, Chen Z, van Doorslaer K. Human papillomaviruses: Genetic basis of carcinogenicity. Public Health Genomics. 2009;12(5–6):281–90. https://doi.org/10.1159/000214919.
Article PubMed PubMed Central Google Scholar
Makvandi M, Rashno M, Faghihloo E, Bagheri S, Hesam S, Mirzaei H, Ramezani A. Low presence of papillomavirus and its lack of correlation with clinicopathological factors in breast cancer: a case control study. Iranian J Microbiol. 2023. https://doi.org/10.18502/ijm.v15i4.13513.
Al-Badawi IA, Al-Suwaine A, Al-Aker M, Asaad L, Alaidan A, Tulbah A, Bohol MF, Munkarah AR. Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. Int J Gynecol Cancer. 2011;21(5):907–10. https://doi.org/10.1097/IGC.0b013e318214219f.
Tadlaoui KA, Ennaji MM. Molecular diagnosis of human papillomavirus related to cervical cancer. In: Oncogenic Viruses. Elsevier; 2023. p. 23–37. https://doi.org/10.1016/B978-0-12-824156-1.00013-3.
Saimul Islam Md, Chakraborty B, Panda CK. Human papilloma virus (HPV) profiles in breast cancer: future management. Annals Trans Med. 2020;8(10):650–650. https://doi.org/10.21037/atm-19-2756.
Salman NA, Davies G, Majidy F, Shakir F, Akinrinade H, Dhayaneethie Perumal G, Ashrafi H. Association of high risk human papillomavirus and breast cancer: a UK based Study. Scientif Rep. 2017. https://doi.org/10.1038/srep43591.
Ng W-K, Cheung LKN, Li ASM, Cheung FMF, Chow JCY. Transitional cell metaplasia of the uterine cervix is related to human papillomavirus: molecular analysis in seven patients with cytohistologic correlation. Cancer. 2002;96(4):250–8. https://doi.org/10.1002/cncr.10722.
Trzcinska A, Zhang W, Gitman M, Westra WH. The prevalence, anatomic distribution and significance of HPV genotypes in head and neck squamous papillomas as detected by real-time PCR and sanger sequencing. Head Neck Pathol. 2020;14(2):428–34. https://doi.org/10.1007/s12105-019-01057-7.
Article CAS PubMed Google Scholar
Sastre-Garau X, Favre M, Couturier J, Orth G (2000) Homo sapiens partial N-myc (exon 3), HPV45 L2, HPV45 L1, HPV45 E6, HPV45 E7 and HPV45 E1 genes isolated from IC4 cervical carcinoma cell line. GenBank: AJ242956. https://www.ncbi.nlm.nih.gov/nuccore/AJ242956
Heydari N, Oskouee MA, Vaezi T, Shoja Z, Esmaeili HA, Hamkar R, Shahmahmoodi S, Jalilvand S (2018) Human papillomavirus 16 isolate CC63 L1 protein (L1) gene, partial cds. GenBank: MF066846. https://www.ncbi.nlm.nih.gov/nuccore/MF066846
Ghobakhloo R, Ebadi M, Shafaati M (2019) Human papillomavirus 16 isolate HPV16/Kp/L1/2019 L1 protein (L1) gene, complete cds. GenBank: MN542782. https://www.ncbi.nlm.nih.gov/nuccore/MN542782
Globocan, World Health Organization (WHO), World Health Organization (WHO). Consulté le: 6 juin 2024. [En ligne]. Disponible sur: https://www.who.int
Dash SR, Kundu A, Kundu CN. The role of viruses in cancer progression versus cancer treatment: a dual paradigm. Life Sci. 2024;341:122506. https://doi.org/10.1016/j.lfs.2024.122506.
Article CAS PubMed Google Scholar
Islam S, Dasgupta H, Roychowdhury A, Bhattacharya R, Mukherjee N, Roy A, Mandal GK, Alam N, Biswas J, Mandal S, Roychoudhury S, Panda CK. Study of association and molecular analysis of human papillomavirus in breast cancer of Indian patients: Clinical and prognostic implication. PLoS ONE. 2017;12(2):e0172760. https://doi.org/10.1371/journal.pone.0172760.
Article CAS PubMed PubMed Central Google Scholar
Gravitt PE, Manos MM. Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. IARC Scientif Publications. 1992;119:121–33.
Da Fonseca AJ, Galvão RS, Miranda AE, Ferreira LCDL, Chen Z. Comparison of three human papillomavirus DNA detection methods: next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing. J Med Virol. 2016;88(5):888–94. https://doi.org/10.1002/jmv.24413.
Article CAS PubMed Google Scholar
Khodabandehlou N, et al. Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins. BMC Cancer. 2019;19(1):61. https://doi.org/10.1186/s12885-019-5286-0.
Article PubMed PubMed Central Google Scholar
Cavalcante JR, et al. Association of breast cancer with human papillomavirus (HPV) infection in Northeast Brazil: molecular evidence. Clinics. 2018;73:e465. https://doi.org/10.6061/clinics/2018/e465.
Article PubMed PubMed Central Google Scholar
Bosch FX, De Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers. 2007;23(4):213–27. https://doi.org/10.1155/2007/914823.
Article PubMed PubMed Central Google Scholar
Aceto GM, et al. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer. Breast Cancer Res Treat. 2010;122(3):671–83. https://doi.org/10.1007/s10549-009-0596-6.
Sher G, et al. Prevalence and type distribution of high-risk human papillomavirus (HPV) in breast cancer: a Qatar based study. Cancers (Basel). 2020;12(6):1528. https://doi.org/10.3390/cancers12061528.
Article CAS PubMed Google Scholar
Delgado-García S, et al. Presence of human papillomavirus DNA in breast cancer: a Spanish case-control study. BMC Cancer. 2017;17(1):320. https://doi.org/10.1186/s12885-017-3308-3.
Article CAS PubMed PubMed Central Google Scholar
Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping. J Gynecol Oncol. 2016;27(2):e21. https://doi.org/10.3802/jgo.2016.27.e21.
Article CAS PubMed Google Scholar
Maldonado-Rodríguez E, et al. Presence of human papillomavirus DNA in Malignant Neoplasia and non-malignant breast disease. Current Issues Mol Biol. 2022;44(8):3648–65.
Pao CC, Hor JJ, Yang FP, Lin CY, Tseng CJ. Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. JCO. 1997;15(3):1008–12. https://doi.org/10.1200/JCO.1997.15.3.1008.
De Villiers E-M, Sandstrom RE, Zur Hausen H, Buck CE. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res. 2004;7(1):R1. https://doi.org/10.1186/bcr940.
Article CAS PubMed PubMed Central Google Scholar
Ferreira DA, Tayyar Y, Idris A, McMillan NAJ. A “hit-and-run” affair – A possible link for cancer progression in virally driven cancers. Biochimica et Biophysica Acta (BBA) - Rev Cancer. 2021;1875(1):188476. https://doi.org/10.1016/j.bbcan.2020.188476.
Yeo-Teh NSL, Ito Y, Jha S. High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis. Int J Mol Sci. 2018;19(6):1706. https://doi.org/10.3390/ijms19061706.
Comments (0)